Cargando…
Cancer Phenotype Diagnosis and Drug Efficacy within Japanese Health Care
An overview on targeted personalized medicine is given describing the developments in Japan of lung cancer patients. These new targeted therapies with novel personalized medicine drugs require new implementations, in order to follow and monitor drug efficacy and outcome. Examples from IRESSA (Gefiti...
Autores principales: | Nishimura, Toshihide, Kato, Harubumi, Ikeda, Norihiko, Kihara, Makoto, Nomura, Masaharu, Kato, Yasufumi, Marko-Varga, György |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364583/ https://www.ncbi.nlm.nih.gov/pubmed/22685658 http://dx.doi.org/10.1155/2012/921901 |
Ejemplares similares
-
A proteomic profiling of laser-microdissected lung adenocarcinoma cells of early lepidic-types
por: Kato, Yasufumi, et al.
Publicado: (2015) -
Clinical initiatives linking Japanese and Swedish healthcare resources on cancer studies utilizing Biobank Repositories
por: Nishimura, Toshihide, et al.
Publicado: (2014) -
A selected reaction monitoring mass spectrometric assessment of biomarker candidates diagnosing large-cell neuroendocrine lung carcinoma by the scaling method using endogenous references
por: Fukuda, Tetsuya, et al.
Publicado: (2017) -
Preferential expression of potential markers for cancer stem cells in large cell neuroendocrine carcinoma of the lung. An FFPE proteomic study
por: Nomura, Masaharu, et al.
Publicado: (2011) -
A proteomic profile of synoviocyte lesions microdissected from formalin-fixed paraffin-embedded synovial tissues of rheumatoid arthritis
por: Hayashi, Junji, et al.
Publicado: (2015)